We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.
- Authors
Lebbé, Céleste; Italiano, Antoine; Houédé, Nadine; Awada, Ahmad; Aftimos, Philippe; Lesimple, Thierry; Dinulescu, Monica; Schellens, Jan H. M.; Leijen, Suzanne; Rottey, Sylvie; Kruse, Vibeke; Kefford, Richard; Raymond, Eric; Faivre, Sandrine; Pages, Celine; Gomez-Roca, Carlos; Schueler, Armin; Goodstal, Samantha; Massimini, Giorgio; Delord, Jean-Pierre
- Publication
Targeted Oncology, 2021, Vol 16, Issue 1, p47
- ISSN
1776-2596
- Publication type
Article
- DOI
10.1007/s11523-020-00767-1